A phase ½, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis - Phatak, P; Brissot, P; Wurster, M; Adams, P C; Bonkovsky, H L; Gross, J; Malfertheiner, P; McLaren, G D; Niederau, C; Piperno, A; Powell, L W; Russo, M W; Stoelzel, U; Stremmel, W; Griffel, L; Lynch, N; Zhang, Y; Pietrangelo, A (Hepatology, 2010)